Sara Ardabili, Markus Hodel, Ines Kaufmann, Stefanie Pelikan, Joachim Kohl
{"title":"The role of second trimester uterine artery doppler using uterine artery score in routine prenatal care in Switzerland","authors":"Sara Ardabili, Markus Hodel, Ines Kaufmann, Stefanie Pelikan, Joachim Kohl","doi":"10.1016/j.ejogrb.2025.114002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>The role of 2nd trimester uterine artery Doppler (UtAd) remains unclear and its implementation varies greatly. Aim of this study was to determine whether 2nd trimester UtAd interpreted with uterine artery score (UAS), a score combining PI and notching in both UtA, is useful in an unselected population in routine care.</div></div><div><h3>Methods</h3><div>We retrospectively calculated the UAS in 503 unselected singleton pregnancies with 2nd trimester scan at 20–24 weeks between 09/2021 and 08/2023 and later delivery in our department and analysed its relationship with perinatal outcome.</div></div><div><h3>Results</h3><div>With UAS > 2 there was a significant increase in adverse perinatal outcome such as hypertension/PE (OR 7.88), SGA (OR 6.82), preterm birth (OR 5.51) and placental abruption (OR 6.89). In contrast, no significant difference was found when comparing UAS 0, 1 and 2. In general, NPV for adverse outcomes were high while PPV were low. In 50 % of SGA-fetuses and 33 % of cases with hypertension/PE in UAS 3–4, the woman had no risk factor.</div></div><div><h3>Conclusion</h3><div>Routine 2nd trimester UtAd is useful in all pregnancies as it can identify additional patients without a pre-existing risk who generally would not be eligible for intense surveillance but still develop PE or SGA later. Further, due to the high NPV, UtAd qualifies as a rule-out tool for adverse outcome even in high-risk pregnancies. To standardise its interpretation, UAS with a cut-off at 2 seems to be a suitable tool for an unselected population. In case of UAS 3–4 a more intense surveillance program should be offered.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"311 ","pages":"Article 114002"},"PeriodicalIF":2.1000,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of obstetrics, gynecology, and reproductive biology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0301211525002775","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
The role of 2nd trimester uterine artery Doppler (UtAd) remains unclear and its implementation varies greatly. Aim of this study was to determine whether 2nd trimester UtAd interpreted with uterine artery score (UAS), a score combining PI and notching in both UtA, is useful in an unselected population in routine care.
Methods
We retrospectively calculated the UAS in 503 unselected singleton pregnancies with 2nd trimester scan at 20–24 weeks between 09/2021 and 08/2023 and later delivery in our department and analysed its relationship with perinatal outcome.
Results
With UAS > 2 there was a significant increase in adverse perinatal outcome such as hypertension/PE (OR 7.88), SGA (OR 6.82), preterm birth (OR 5.51) and placental abruption (OR 6.89). In contrast, no significant difference was found when comparing UAS 0, 1 and 2. In general, NPV for adverse outcomes were high while PPV were low. In 50 % of SGA-fetuses and 33 % of cases with hypertension/PE in UAS 3–4, the woman had no risk factor.
Conclusion
Routine 2nd trimester UtAd is useful in all pregnancies as it can identify additional patients without a pre-existing risk who generally would not be eligible for intense surveillance but still develop PE or SGA later. Further, due to the high NPV, UtAd qualifies as a rule-out tool for adverse outcome even in high-risk pregnancies. To standardise its interpretation, UAS with a cut-off at 2 seems to be a suitable tool for an unselected population. In case of UAS 3–4 a more intense surveillance program should be offered.
期刊介绍:
The European Journal of Obstetrics & Gynecology and Reproductive Biology is the leading general clinical journal covering the continent. It publishes peer reviewed original research articles, as well as a wide range of news, book reviews, biographical, historical and educational articles and a lively correspondence section. Fields covered include obstetrics, prenatal diagnosis, maternal-fetal medicine, perinatology, general gynecology, gynecologic oncology, uro-gynecology, reproductive medicine, infertility, reproductive endocrinology, sexual medicine and reproductive ethics. The European Journal of Obstetrics & Gynecology and Reproductive Biology provides a forum for scientific and clinical professional communication in obstetrics and gynecology throughout Europe and the world.